Search Results
Results found for "Dr. Ben Myers"
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- Why “Displacement” Misleads You: Allosteric Binding Demystified
As a member, you’ll get: Weekly expert-led lectures from Dr.
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
premium member , you can access over 500 minutes of exclusive, expert-led content from esteemed leaders, Drs
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Subscribers gain access to: Weekly lessons by Dr.
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
Here ’s what members get: Weekly deep dives from Dr.
- How GPCR Collaboration Built an Innovation Engine
. 🎧 Listen to the full episode: Leadership, Luck, and GPCR Signaling 🔓 Join Dr.
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Thank you to all participants in Dr. Terry Kenakin's educational initiative this fall!
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
At Dr. GPCR, we recognized this core problem.
- 📰 GPCR Weekly News - January 2 to 8, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
postdoctoral training at Boston Children’s Hospital and Harvard Medical School, he joined the lab of Dr
- How Collaboration Drives GPCR Discoveries
. 🎧 Listen to the full conversation with Dr. David Hodson
- 📰 GPCR Weekly News, January 23 to 29, 2023
of Staff Postdoctoral Fellow, Biochemical And Cellular Pharmacology Project Leader, Biology Explore Dr
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Monthly AMAs where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.
- 📰 GPCR Weekly News - January 9 to 15, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with ...
Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with Tim Dyer Addex Therapeutics "Tim Dyer is the Co-Founder and CEO of Addex Therapeutics, which is focusing on the
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
It's starting to look a lot like Christmas at Dr. GPCR!
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- GPCR Buzz of the Week | Sep 23 - 29, 2024
live and work in a developing country, please complete this form to enjoy complimentary access to Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
Tim Dyer, CEO, Roger Mills, CMO and Robert Lütjens, Head of Discovery Biology, will provide a business
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
3D was used to predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
strategic priorities, including pursuing additional collaborations across our portfolio,” said Tim Dyer
- Adhesion GPCR Consortium Newsletter - May 2024
postdoctoral training, I joined one of the labs that participated in Latrophilins’ discovery, the lab of Dr
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Dr. Rößler P, Mayer D, Tsai CJ, Veprintsev DB, Schertler GFX, Gossert AD.
- Glyco-sulfo hotspots in the chemokine receptor system
which have an established role in chemokine gradients and oligomerization (Deshauer C et al. 2015; Dyer
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Iyer, M. R.; Cinar, R.; Coffey, N.
